Skip to main content
Clinical Trials/NCT04321759
NCT04321759
Recruiting
Not Applicable

Comparative Effectiveness of Cognitive Enhancement Therapy vs. Social Skills Training in Serious Mental Illness

Beth Israel Deaconess Medical Center5 sites in 1 country378 target enrollmentJune 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Schizophrenia and Related Disorders
Sponsor
Beth Israel Deaconess Medical Center
Enrollment
378
Locations
5
Primary Endpoint
Change in Social Adjustment Scale II
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

To compare two evidence-based treatments, Cognitive Enhancement Therapy (CET) and Social Skills Training (SST) that have been shown in meta-analyses and in our own research to be effective to improve community functioning. The investigators will test the impact of CET and SST on community functioning, with special attention to their relative effectiveness for patients differing in baseline cognitive skills and age. The research uses a cluster design in which different mental health service centers are randomized to one of the two treatments.

Detailed Description

Aim 1. We will test our hypothesis that CET will be associated with greater improvements than SST in both the primary outcome: community functioning (SAS, QLS), and the secondary outcomes of neuro- and social cognition (NIH Toolbox, PennCNB, and MSCEIT) and social skills (SSPA). For study Aim 1, we hypothesized that CET will be associated with greater improvements than SST in both the primary outcome: community functioning (SAS, QLS), and the secondary outcomes of neuro- and social cognition (selected NIH Toolbox and Penn CNB measures, and MSCEIT) and social skills (SSPA). Aim 2: We will explore differential effectiveness of the two interventions by baseline cognitive functioning and age. For Aim 2, we hypothesize that patients with less impairment in cognitive functioning at baseline will demonstrate relatively larger treatment gains in SST compared to those in CET than those who are initially more cognitively impaired, and that younger patients will benefit more from CET compared to those in SST than those who are older. The results of this study will address a key knowledge gap in the field and a decisional dilemma for clinicians. A pilot study at four treatment sites will be used to test the feasibility and acceptability of telementalhealth delivery of these two treatments, as compared to in-person delivery.

Registry
clinicaltrials.gov
Start Date
June 1, 2021
End Date
January 31, 2026
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Matcheri S. Keshavan MD

Stanley Cobb Professor and Academic Head of Psychiatry, Department of Psychiatry,

Beth Israel Deaconess Medical Center

Eligibility Criteria

Inclusion Criteria

  • age 18 to 65;
  • DSM-5 diagnosis of schizophrenia or schizoaffective or schizophreniform disorder (confirmed via the MINI diagnostic interview);
  • estimated IQ of \> 70 (established via WTAR).

Exclusion Criteria

  • the presence of a current organic brain syndrome;
  • intellectual disability (DSM-5);
  • participation in either CET or SST within the prior year.

Outcomes

Primary Outcomes

Change in Social Adjustment Scale II

Time Frame: Measurement at 0, 6, 12, 18, 24 months

Measure of social functioning

Change in Social Skills Performance Assessment

Time Frame: Measurement at 0, 6, 12, 18, 24 months

Measure of social functioning using role played scenarios

Change in Heinrich Quality of Life Scale

Time Frame: Measurement at 0, 6, 12, 18, 24 months

Measure of social functioning

Secondary Outcomes

  • Change in Picture Sequence Memory(Measurement at 0, 6, 12, 18, 24 months)
  • Change in Auditory Verbal Learning Test(Measurement at 0, 6, 12, 18, 24 months)
  • Change in Picture Vocabulary(Measurement at 0, 6, 12, 18, 24 months)
  • Change in Penn Digit Symbol Test(Measurement at 0, 6, 12, 18, 24 months)
  • Change in List Sorting Working Memory(Measurement at 0, 6, 12, 18, 24 months)
  • Change in Positive and Negative Syndrome Scale, PANSS-6(Measurement at 0, 6, 12, 18, 24 months)
  • Change in Oral Reading Recognition(Measurement at 0, 6, 12, 18, 24 months)
  • Change in Penn Mouse Practice Test(Measurement at 0, 6, 12, 18, 24 months)
  • Change in Penn Conditional Exclusion Test(Measurement at 0, 6, 12, 18, 24 months)
  • Change in Penn Continuous Performance Test(Measurement at 0, 6, 12, 18, 24 months)
  • Change in Managing Emotions(Measurement at 0, 6, 12, 18, 24 months)

Study Sites (5)

Loading locations...

Similar Trials